PHG vs BIO
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Jul 14, 2026
PHG
BIO
Investment Advisor Scores
AI Analyst Insights
Detailed Metrics Comparison
| Metric | PHG | BIO | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 15.4321 | 33.4448 | PHG |
| PEG Ratio | 0.9181 | 1.1905 | PHG |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -4.7% | 1.1% | BIO |
| Earnings Growth | 97.2% | -83.0% | PHG |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 61.2/100 | 62.7/100 | BIO |
| Profit Margin | 5.5% | 6.5% | BIO |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | BUY | BUY | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
PHG
DistributionPrice near a flattening SMA50 (slope 0.1%) with fading momentum, RSI 48
BIO
MarkupPrice above SMA50, rising 50-day trend (6.1% over 20 days), RSI 70
Fundamentals Snapshot
| Metric | PHG | BIO |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 13.8 | 33.5 |
| Trailing P/E | 19.6 | 54.4 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.0% | 0.0% |
| Gross Margin | 0.5% | 0.5% |
| Operating Margin | 0.1% | 0.1% |
| EPS | 1.33 | 6.01 |
| Dividend Yield | 0.04% | — |